Comment

Comment

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • SA has world class medical researchers – they can and should be bailed out

    The sudden and severe US cuts to grants from the world’s largest health research funder threaten to unravel the medical research landscape in South Africa. A crucial question now is whether the government will turn this crisis into an opportunity for renewal, write Marcus Low and Nathan Geffen.

    ·

  • Who can prescribe medicines in SA?

    What medicines do you need prescriptions for and who is authorised to write those prescriptions is not a straight-forward matter. In his latest Inside The Box column, Dr Andy Gray explains how the system works now and sets out how it might be improved.

    ·

  • What does it mean for health? SAMRC experts weigh in on budget 2025

    While the 2025 national budget boosts health spending, researchers from the South African Medical Research Council stress the need for strong accountability measures. They also raise concerns about rising VAT and omissions related to US funding cuts and climate change.

    ·

  • Stopping health funding in Africa weakens America

    Following President Donald Trump’s decision to suspend foreign aid, President Cyril Ramaphosa can display great leadership by meeting with leaders of wealthy countries and convincing them to increase spending to support the health systems of poorer countries, write Nathan Geffen and Marcus Low.

    ·

  • Health in 2025 | Spotlight’s top 4 questions for the year ahead

    From the ongoing political and legal battles over NHI, to the far-reaching health impacts of political change in the United States, it is set to be another tumultuous year for healthcare in South Africa and around the globe. Here’s Spotlight’s top four healthcare questions for 2025.

    ·

  • South Africa’s AIDS response: Progress, challenges, and opportunities

    Ahead of World AIDS Day 2024, Professor Salim Abdool Karim and Dr Nikita Devnarain argue that South Africa needs a concerted effort to reduce new HIV infections in young women and to prepare for the rollout of long-acting forms of HIV prevention alongside a well-functioning HIV treatment programme.

    ·

  • Why the fuss about long-acting antiretrovirals for HIV?

    HIV prevention injections that can provide two, or even six, months of protection per shot have arguably been the biggest HIV story of the year. Ahead of World AIDS Day, Professor Francois Venter assesses the state of play and the critical next steps with these potentially game-changing new tools in the fight against HIV.

    ·

  • NHI offers an opportunity to boost primary healthcare – we must seize it

    To see National Health Insurance primarily as the setting up of a state-run medical aid scheme risks underplaying its massive potential to restructure how public healthcare services are organised and funded, and with that, its potential to boost the delivery of primary healthcare services in South Africa, argues Russell Rensburg.

    ·